You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moxetumomab pasudotox

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hairy Cell Leukemia Trial run by the NCI (Moxetumomab Pasudotox-tdfk, Rituximab, Ruxience)

Active, not recruiting
  • Hairy Cell Leukemia
  • Moxetumomab Pasudotox-tdfk
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

Moxetumomab Pasudotox-tdfk (LUMOXITI)

Recruiting
  • Hairy Cell Leukemia
    • Pueblo, Colorado
    • +1 more
    Aug 17, 2022

    Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

    Approved for marketing
    • Relapsed/Refractory Hairy Cell Leukemia
    • Moxetumomab Pasudotox
    • (no location specified)
    Jun 26, 2020

    Leukemia Trial in Houston (Moxetumomab Pasudotox)

    Terminated
    • Leukemia
    • Moxetumomab Pasudotox
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Feb 10, 2020

    Leukemia, Hairy Cell Trial in Worldwide (Moxetumomab pasudotox, IV Bag Protectant for Moxetumomab pasudotox)

    Completed
    Has Results
    • Leukemia, Hairy Cell
    • Moxetumomab pasudotox
    • IV Bag Protectant for Moxetumomab pasudotox
    • Duarte, California
    • +33 more
    Mar 27, 2020

    Reporting of Antibody-Drug Conjugate Associated Sepsis-related

    Completed
    • Sepsis (SMQ)
    • +2 more
    • Antibody-Drug Conjugate
    • Antineoplastic and immunomodulating agents other than Antibody-Drug Conjugate
    • Changsha, Hunan, China
      Central South University
    Jun 19, 2022

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Hairy Cell Leukemia Trial in Poland, United States (Moxetumomab Pasudotox (CAT 8015), CAT 8015 (Moxetumomab Pasudotox))

    Completed
    Has Results
    • Hairy Cell Leukemia
    • Moxetumomab Pasudotox (CAT 8015)
    • CAT 8015 (Moxetumomab Pasudotox)
    • Stanford, California
    • +3 more
    Jan 2, 2019

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Cancer Target Therapy Efficacy

      Active, not recruiting
      • Cancer
      • RNA sequencing
      • +5 more
      • Walnut, California
      • +6 more
      Sep 13, 2021

      Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Canada, United States (CAT-8015 (Moxetumomab Pasudotox))

      Completed
      Has Results
      • Acute Lymphoblastic Leukemia
      • Non-Hodgkin's Lymphoma
      • CAT-8015 (Moxetumomab Pasudotox)
      • Los Angeles, California
      • +4 more
      Aug 28, 2017

      Leukemia, Lymphoma, Chronic Lymphocytic, Leukemia, Prolymphocytic Leukemia, Small, Lymphocytic Lymphoma, Moxetumomab Pasudotox

      Terminated
      Has Results
      • Leukemia, Lymphoma, Chronic Lymphocytic
      • +2 more
      • CAT-8015 5 mcg/kg
      • +2 more
      • Indianapolis, Indiana
      • +2 more
      Jun 12, 2017

      B-Cell Pediatric ALL Trial in Worldwide (Moxetumomab Pasudotox)

      Terminated
      Has Results
      • B-Cell Pediatric ALL
      • Moxetumomab Pasudotox
      • Phoenix, Arizona
      • +20 more
      Mar 9, 2017

      Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Poland, United States (CAT-8015 20 mcg/kg, CAT-8015 30 mcg/kg,

      Completed
      Has Results
      • Non-Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • CAT-8015 20 mcg/kg
      • +4 more
      • Los Angeles, California
      • +7 more
      Mar 12, 2018

      Acute Lymphoblastic Leukemia (ALL) Trial in United States (Moxetumomab Pasudotox)

      Terminated
      • Acute Lymphoblastic Leukemia (ALL)
      • Moxetumomab Pasudotox
      • Los Angeles, California
      • +3 more
      Sep 15, 2015